ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

 News | News By Subject | News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Teva Pharmaceutical Industries Limited (TEVA) May Raise Forecast After Provigil Decision, Analyst Says


4/10/2012 7:24:56 AM

Teva Pharmaceutical Industries Ltd. (TEVA) may raise its earnings forecast when it reports results next month to reflect the U.S. Food and Drug Administration’s decision on the narcolepsy drug Provigil, an analyst said. “Teva’s estimates are looking conservative following the Provigil announcement,” Natali Gotlieb, an analyst for Israel Brokerage & Investments Ltd., said in an interview in Tel Aviv. “Though Teva tends to be conservative with their guidance, there’s a chance they will increase their guidance in their first-quarter conference call.”

Read at Bloomberg
 
 Read Article at  Related Companies  News Categories
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES